LemonBox Health

lemonbox.com →

-71%

est. 2Y upside i

HealthcareSeries A

From vitamins to meals, AI that optimizes your daily nutrition.

Rank

#1702

Sector

HealthTech, Personalized Nutrition

Est. Liquidity

~4Y

Data Quality

Data: Low

LemonBox Health operates in a high-growth personalized nutrition market in China (projected to reach over $5B by 2033) with a differentiated D2C model.

Last updated: March 10, 2026

Bull (20%)+300%

LemonBox successfully leverages its personalized, D2C model and U.S.-made supplements to capture significant share in China's rapidly growing personalized nutrition market (CAGR ~18% to $5.2B by 2033). Strategic partnerships and successful expansion onto major e-commerce platforms like Alibaba drive revenue growth, attracting a Series B round at a $120M valuation, a 4x increase from the current estimate.

Base (40%)+75%

LemonBox maintains its niche in the personalized vitamin market for Chinese millennials, achieving steady but not explosive growth. It continues to navigate regulatory complexities and moderate competition, reaching a $52.5M valuation (1.75x current estimate) through organic growth and perhaps a small bridge round, making it an attractive acquisition target for a larger health or e-commerce player.

Bear (40%)-80%

LemonBox struggles to overcome high regulatory barriers and intense competition from dominant incumbents like Amway and well-funded global players (e.g., Nestlé Health Science). Without significant further funding beyond its $4.5M total, growth stalls, leading to a down round or a low-value acquisition at a $6M valuation, wiping out most common stock value.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Investors hold $4.5M in liquidation preferences, representing 15% of the estimated $30M current valuation.

Dilution Risk

high

Given the Series A stage and limited total funding, significant future funding rounds are likely required, leading to substantial employee equity dilution.

Secondary Liquidity

none

As an early-stage, privately held company, there is no active secondary market or tender offers for employee equity.

Questions to Ask at the Interview

Strategic questions based on LemonBox Health's data — designed to show you've done your homework.

  • 1

    “Given the high regulatory barriers in China for health supplements, what specific strategies are in place to ensure ongoing compliance and how do you view the evolving regulatory landscape impacting your long-term growth plans?”

  • 2

    “LemonBox's last announced funding was a Series A in October 2021. How has the company managed its capital efficiently since then, and what is the strategy for securing future funding rounds to scale operations against well-funded competitors?”

  • 3

    “With dominant incumbents like Amway in the traditional Chinese vitamin market and global players like Nestlé Health Science expanding into personalized nutrition, how does LemonBox plan to strengthen its competitive moat and defend its market position over the next 2-3 years?”

Community

Valuation Sentiment

Our model estimates -71% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.